Skip to content
TrialScanner

NCT00351949

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Phase 1CompletedIMMPLead

Registry record

Lead sponsor
Immutep S.A.S.
Conditions
Stage IV Renal Cell Carcinoma
Primary completion
Aug 2008Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00351949 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00351949: IMP321 Phase 1 Trial in... | TrialScanner